Evidence map›Paper›PMID 28328065›Full record

Trial reportActa paediatrica (Oslo, Norway : 1992)2017

Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic.

Yvan Vandenplas, Thomas Ludwig, Hetty Bouritius, Philippe Alliet, Derek Forde, Stefaan Peeters, Frederic Huet, Jonathan Hourihane

Open access · hybridAbstract readEquivalence TrialMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Acta paediatrica (Oslo, Norway : 1992), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Dietary modifications for infantile colic.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Postbiotics as Metabolites and Their Biotherapeutic Potential.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Yvan VandenplasDepartment of Pediatrics, UZ, Vrije Universiteit Brussel, Brussels, Belgium.
Thomas LudwigNutricia Research, Utrecht, The Netherlands.
Hetty BouritiusNutricia Research, Utrecht, The Netherlands.
Philippe AllietKinderartsenpraktijk, Hasselt, Belgium.
Derek FordeSlaney Medical Centre, Enniscorthy, Ireland.
Stefaan PeetersAlgemeen Stedelijk Ziekenhuis Aalst, Aalst, Belgium.
Frederic HuetPédiatrie, Hôpital d'Enfants, Dijon, France.
Jonathan HourihanePaediatrics and Child Health, University College Cork, Cork, Ireland.
Nutricia Research (Netherlands) · NLHôpital d'Enfants · FROnze Lieve Vrouwziekenhuis Hospital · BEUniversity College Cork · IEVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe examined the effects on gastrointestinal (GI) tolerance of a novel infant formula that combined specific fermented formula (FERM) with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides (scGOS/lcFOS), with a 9:1 ratio and concentration of 0.8 g/100 mL.

methodsThis prospective, double-blind, randomised, controlled trial comprised 432 healthy, term infants aged 0-28 days whose parents decided to not start, or discontinued, breastfeeding. Infant formula with scGOS/lcFOS+50%FERM, scGOS/lcFOS+15%FERM, 50%FERM and scGOS/lcFOS were tested. Parents completed standardised seven-day diaries on GI symptoms, crying, sleeping and stool characteristics each month until the infants were 17 weeks.

resultsAll the formulas were well tolerated. At four weeks, the overall incidence of infantile colic was significantly lower (8%) with scGOS/lcFOS+50%FERM than scGOS/lcFOS (20%, p = 0.034) or 50%FERM (20%, p = 0.036). Longitudinal modelling showed that scGOS/lcFOS+50%FERM-fed infants also displayed a persistently lower daily crying duration and showed a consistent stool-softening effect than infants who received formula without scGOS/lcFOS.

conclusionThe combination of fermented formula with scGOS/lcFOS was well tolerated and showed a lower overall crying time, a lower incidence of infantile colic and a stool-softening effect in healthy term infants. These findings suggest for the first time that a specific infant formula has a preventive effect on infantile colic in formula-fed infants.

Indexed as

Cultured Milk ProductsInfant FormulaPrebioticsColicCryingDouble-Blind MethodHumansInfantInfant, NewbornOligosaccharidesProspective StudiesOligosaccharidesPrebioticsFermented formulaGastrointestinal toleranceInfant formulaInfantile colicPrebiotic

Identifiers

PMID28328065
PMCPMC5485044
OpenAlexW2599256313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.